These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 9201142)

  • 1. Early hospital discharge of children with fever and neutropenia: a prospective study.
    Wacker P; Halperin DS; Wyss M; Humbert J
    J Pediatr Hematol Oncol; 1997; 19(3):208-11. PubMed ID: 9201142
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety and cost effectiveness of early hospital discharge of lower risk children with cancer admitted for fever and neutropenia.
    Bash RO; Katz JA; Cash JV; Buchanan GR
    Cancer; 1994 Jul; 74(1):189-96. PubMed ID: 8004575
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A prospective multicenter study of microbiologically defined infections in pediatric cancer patients with fever and neutropenia: Swiss Pediatric Oncology Group 2003 fever and neutropenia study.
    Agyeman P; Kontny U; Nadal D; Leibundgut K; Niggli F; Simon A; Kronenberg A; Frei R; Escobar H; Kühne T; Beck-Popovic M; Bodmer N; Ammann RA
    Pediatr Infect Dis J; 2014 Sep; 33(9):e219-25. PubMed ID: 24618935
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk-adapted approach for fever and neutropenia in paediatric cancer patients--a national multicentre study.
    Miedema KG; Tissing WJ; Abbink FC; Ball LM; Michiels EM; van Vliet MJ; de Vries WY; Kamps WA; Norbruis OF; Fiocco M; de Groot-Kruseman HA; van de Wetering MD; de Bont ES
    Eur J Cancer; 2016 Jan; 53():16-24. PubMed ID: 26700076
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early hospital discharge of children with cancer treated for fever and neutropenia: identification and management of the low-risk patient.
    Mullen CA; Buchanan GR
    J Clin Oncol; 1990 Dec; 8(12):1998-2004. PubMed ID: 2230891
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cessation of antibiotics regardless of ANC is safe in children with febrile neutropenia. A preliminary prospective trial.
    Cohen KJ; Leamer K; Odom L; Greffe B; Stork L
    J Pediatr Hematol Oncol; 1995 Nov; 17(4):325-30. PubMed ID: 7583388
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomized comparison of antibiotics with and without granulocyte colony-stimulating factor in children with chemotherapy-induced febrile neutropenia: a report from the Children's Oncology Group.
    Ozkaynak MF; Krailo M; Chen Z; Feusner J
    Pediatr Blood Cancer; 2005 Sep; 45(3):274-80. PubMed ID: 15806544
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The influence of different fever definitions on diagnostics and treatment after diagnosis of fever in chemotherapy-induced neutropenia in children with cancer.
    Wagner S; Brack EK; Stutz-Grunder E; Agyeman P; Leibundgut K; Teuffel O; Ammann RA
    PLoS One; 2018; 13(2):e0193227. PubMed ID: 29462193
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral ciprofloxacin in the management of children with cancer with lower risk febrile neutropenia.
    Paganini H; Rodriguez-Brieshcke T; Zubizarreta P; Latella A; Firpo V; Casimir L; Armada A; Fernández C; Cáceres E; Debbag R
    Cancer; 2001 Apr; 91(8):1563-7. PubMed ID: 11301406
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of urinary tract infections among febrile young children with daily intravenous antibiotic therapy at a day treatment center.
    Gauthier M; Chevalier I; Sterescu A; Bergeron S; Brunet S; Taddeo D
    Pediatrics; 2004 Oct; 114(4):e469-76. PubMed ID: 15466073
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk factors for recurrent fever after the discontinuation of empiric antibiotic therapy for fever and neutropenia in pediatric patients with a malignancy or hematologic condition.
    Jones GR; Konsler GK; Dunaway RP; Gold SH; Cooper HA; Wells RJ
    J Pediatr; 1994 May; 124(5 Pt 1):703-8. PubMed ID: 8176555
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of febrile neutropenia in solid tumours and lymphomas using the Multinational Association for Supportive Care in Cancer (MASCC) risk index: feasibility and safety in routine clinical practice.
    Innes H; Lim SL; Hall A; Chan SY; Bhalla N; Marshall E
    Support Care Cancer; 2008 May; 16(5):485-91. PubMed ID: 17899215
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Etiology and clinical course of febrile neutropenia in children with cancer.
    Hakim H; Flynn PM; Knapp KM; Srivastava DK; Gaur AH
    J Pediatr Hematol Oncol; 2009 Sep; 31(9):623-9. PubMed ID: 19644403
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deficiency of mannose-binding lectin-associated serine protease-2 associated with increased risk of fever and neutropenia in pediatric cancer patients.
    Schlapbach LJ; Aebi C; Otth M; Leibundgut K; Hirt A; Ammann RA
    Pediatr Infect Dis J; 2007 Nov; 26(11):989-94. PubMed ID: 17984804
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hematologic predictors of bone marrow recovery in neutropenic patients hospitalized for fever: implications for discontinuation of antibiotics and early discharge from the hospital.
    Griffin TC; Buchanan GR
    J Pediatr; 1992 Jul; 121(1):28-33. PubMed ID: 1625089
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A double-blind comparison of empirical oral and intravenous antibiotic therapy for low-risk febrile patients with neutropenia during cancer chemotherapy.
    Freifeld A; Marchigiani D; Walsh T; Chanock S; Lewis L; Hiemenz J; Hiemenz S; Hicks JE; Gill V; Steinberg SM; Pizzo PA
    N Engl J Med; 1999 Jul; 341(5):305-11. PubMed ID: 10423464
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Short courses of intravenous empirical antibiotic treatment in selected febrile neutropenic children with cancer.
    Lehrnbecher T; Stanescu A; Kühl J
    Infection; 2002 Jan; 30(1):17-21. PubMed ID: 11876510
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Granulocyte colony-stimulating factor in the treatment of high-risk febrile neutropenia: a multicenter randomized trial.
    García-Carbonero R; Mayordomo JI; Tornamira MV; López-Brea M; Rueda A; Guillem V; Arcediano A; Yubero A; Ribera F; Gómez C; Trés A; Pérez-Gracia JL; Lumbreras C; Hornedo J; Cortés-Funes H; Paz-Ares L
    J Natl Cancer Inst; 2001 Jan; 93(1):31-8. PubMed ID: 11136839
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomized comparison of cefepime versus ceftazidime monotherapy for fever and neutropenia in children with solid tumors.
    Kebudi R; Görgün O; Ayan I; Gürler N; Akici F; Töreci K
    Med Pediatr Oncol; 2001 Apr; 36(4):434-41. PubMed ID: 11260566
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of febrile neutropenia in patients receiving chemotherapy for solid tumors: a retrospective study of twenty cases from the radiotherapy centre, Accra, Ghana.
    Vanderpuye V; Yarney J; Beecham K
    West Afr J Med; 2010; 29(5):303-8. PubMed ID: 21089015
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.